The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment modification with sunitinib in first-line (1L) metastatic renal cell carcinoma (mRCC): An analysis of the STAR-TOR registry.
 
Martin Boegemann
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Janssen; Novartis
 
Marcus Hubbe
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Despina Thomaidou
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Stuart Blackburn
Consulting or Advisory Role - Pfizer (Inst)
Research Funding - Pfizer (Inst)
 
Nawal Bent-Ennakhil
Consulting or Advisory Role - Pfizer (Inst)
Research Funding - Pfizer (Inst)
 
Robert Wood
Consulting or Advisory Role - Pfizer (Inst)
Research Funding - Pfizer (Inst)
 
Danielle Bargo
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer